{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COPD", "aging", "antioxidant", "oxidative stress", "thioredoxin"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34573061", "DateRevised": {"Year": "2021", "Month": "10", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "09", "Day": "07"}], "ELocationID": ["1429", "10.3390/antiox10091429"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "07"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD.", "Abstract": {"AbstractText": ["Mammals, including humans, are aerobic organisms with a mature respiratory system to intake oxygen as a vital source of cellular energy. Despite the essentiality of reactive oxygen species (ROS) as byproducts of aerobic metabolism for cellular homeostasis, excessive ROS contribute to the development of a wide spectrum of pathological conditions, including chronic lung diseases such as COPD. In particular, epithelial cells in the respiratory system are directly exposed to and challenged by exogenous ROS, including ozone and cigarette smoke, which results in detrimental oxidative stress in the lungs. In addition, the dysfunction of redox regulation due to cellular aging accelerates COPD pathogenesis, such as inflammation, protease anti-protease imbalance and cellular apoptosis. Therefore, various drugs targeting oxidative stress-associated pathways, such as thioredoxin and N-acetylcysteine, have been developed for COPD treatment to precisely regulate the redox system. In this review, we present the current understanding of the roles of redox regulation in the respiratory system and COPD pathogenesis. We address the insufficiency of current COPD treatment as antioxidants and discuss future directions in COPD therapeutics targeting oxidative stress while avoiding side effects such as tumorigenesis."]}, "AuthorList": [{"Identifier": ["0000-0001-8207-9688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Regenerative Medicine, Boston Medical Center, Boston University, Boston, MA 02118, USA."}], "LastName": "Kiyokawa", "ForeName": "Hirofumi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kakeyu-Misayama Rehabilitation Center, 1308 Kakeyu-onsen, Ueda, Nagano 386-0396, Japan."}], "LastName": "Hoshino", "ForeName": "Yuma", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan."}], "LastName": "Sakaguchi", "ForeName": "Kazuhiro", "Initials": "K"}, {"Identifier": ["0000-0001-7452-9191"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan."}], "LastName": "Muro", "ForeName": "Shigeo", "Initials": "S"}, {"Identifier": ["0000-0001-6849-4914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Japan Biostress Research Promotion Alliance (JBPA), 1-6 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan."}, {"Identifier": [], "Affiliation": "Institute for Virus Research, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan."}], "LastName": "Yodoi", "ForeName": "Junji", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Agarwal A., Aponte-Mellado A., Premkumar B.J., Shaman A., Gupta S. The effects of oxidative stress on female reproduction: A review. Reprod. Biol. Endocrinol. 2012;10:49. doi: 10.1186/1477-7827-10-49.", "ArticleIdList": ["10.1186/1477-7827-10-49", "PMC3527168", "22748101"]}, {"Citation": "Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094\u20134125. doi: 10.1007/s12035-015-9337-5.", "ArticleIdList": ["10.1007/s12035-015-9337-5", "PMC4937091", "26198567"]}, {"Citation": "Checa J., Aran J.M. Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. Int. J. Mol. Sci. 2020;21:9317. doi: 10.3390/ijms21239317.", "ArticleIdList": ["10.3390/ijms21239317", "PMC7731288", "33297418"]}, {"Citation": "Global Initiative for Chronic Obstructive Lung Disease  Global Strategy for Prevention, Diagnosis and Management of COPD. 2020.  [(accessed on 1 September 2021)].  Available online:  https://goldcopd.org/gold-reports/"}, {"Citation": "Pryor W.A., Prier D.G., Church D.F. Electron-spin resonance study of mainstream and sidestream cigarette smoke: Nature of the free radicals in gas-phase smoke and in cigarette tar. Environ. Health Perspect. 1983;47:345\u2013355. doi: 10.1289/ehp.8347345.", "ArticleIdList": ["10.1289/ehp.8347345", "PMC1569403", "6297881"]}, {"Citation": "Barnes P.J. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544. doi: 10.1016/j.redox.2020.101544.", "ArticleIdList": ["10.1016/j.redox.2020.101544", "PMC7251237", "32336666"]}, {"Citation": "Mercado N., Ito K., Barnes P.J. Accelerated ageing of the lung in COPD: New concepts. Thorax. 2015;70:482\u2013489. doi: 10.1136/thoraxjnl-2014-206084.", "ArticleIdList": ["10.1136/thoraxjnl-2014-206084", "25739910"]}, {"Citation": "Wickens A.P. Ageing and the free radical theory. Respir. Physiol. 2001;128:379\u2013391. doi: 10.1016/S0034-5687(01)00313-9.", "ArticleIdList": ["10.1016/S0034-5687(01)00313-9", "11718765"]}, {"Citation": "Schneider J.L., Rowe J.H., Garcia-de-Alba C., Kim C.F., Sharpe A.H., Haigis M.C. The aging lung: Physiology, disease, and immunity. Cell. 2021;184:1990\u20132019. doi: 10.1016/j.cell.2021.03.005.", "ArticleIdList": ["10.1016/j.cell.2021.03.005", "PMC8052295", "33811810"]}, {"Citation": "Kinoshita T., Hoshino T., Imaoka H., Ichiki H., Okamoto M., Kawayama T., Yodoi J., Kato S., Aizawa H. Thioredoxin prevents the development and progression of elastase-induced emphysema. Biochem. Biophys. Res. Commun. 2007;354:712\u2013719. doi: 10.1016/j.bbrc.2007.01.053.", "ArticleIdList": ["10.1016/j.bbrc.2007.01.053", "17257583"]}, {"Citation": "Hoshino Y., Mishima M. Redox-based therapeutics for lung diseases. Antioxid. Redox Signal. 2008;10:701\u2013704. doi: 10.1089/ars.2007.1961.", "ArticleIdList": ["10.1089/ars.2007.1961", "18177233"]}, {"Citation": "Matera M.G., Calzetta L., Cazzola M. Oxidation pathway and exacerbations in COPD: The role of NAC. Expert Rev. Respir. Med. 2016;10:89\u201397. doi: 10.1586/17476348.2016.1121105.", "ArticleIdList": ["10.1586/17476348.2016.1121105", "26567752"]}, {"Citation": "Kowaltowski A.J., de Souza-Pinto N.C., Castilho R.F., Vercesi A.E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 2009;47:333\u2013343. doi: 10.1016/j.freeradbiomed.2009.05.004.", "ArticleIdList": ["10.1016/j.freeradbiomed.2009.05.004", "19427899"]}, {"Citation": "Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell. 2012;48:158\u2013167. doi: 10.1016/j.molcel.2012.09.025.", "ArticleIdList": ["10.1016/j.molcel.2012.09.025", "PMC3484374", "23102266"]}, {"Citation": "Nolfi-Donegan D., Braganza A., Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674. doi: 10.1016/j.redox.2020.101674.", "ArticleIdList": ["10.1016/j.redox.2020.101674", "PMC7767752", "32811789"]}, {"Citation": "Holmstrom K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014;15:411\u2013421. doi: 10.1038/nrm3801.", "ArticleIdList": ["10.1038/nrm3801", "24854789"]}, {"Citation": "Watson W.H., Ritzenthaler J.D., Roman J. Lung extracellular matrix and redox regulation. Redox Biol. 2016;8:305\u2013315. doi: 10.1016/j.redox.2016.02.005.", "ArticleIdList": ["10.1016/j.redox.2016.02.005", "PMC4777985", "26938939"]}, {"Citation": "Bae Y.S., Oh H., Rhee S.G., Yoo Y.D. Regulation of reactive oxygen species generation in cell signaling. Mol. Cells. 2011;32:491\u2013509. doi: 10.1007/s10059-011-0276-3.", "ArticleIdList": ["10.1007/s10059-011-0276-3", "PMC3887685", "22207195"]}, {"Citation": "Miki H., Funato Y. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J. Biochem. 2012;151:255\u2013261. doi: 10.1093/jb/mvs006.", "ArticleIdList": ["10.1093/jb/mvs006", "22287686"]}, {"Citation": "Tew K.D., Townsend D.M. Glutathione-s-transferases as determinants of cell survival and death. Antioxid. Redox Signal. 2012;17:1728\u20131737. doi: 10.1089/ars.2012.4640.", "ArticleIdList": ["10.1089/ars.2012.4640", "PMC3474190", "22540427"]}, {"Citation": "Hoshino Y., Shioji K., Nakamura H., Masutani H., Yodoi J. From oxygen sensing to heart failure: Role of thioredoxin. Antioxid. Redox Signal. 2007;9:689\u2013699. doi: 10.1089/ars.2007.1575.", "ArticleIdList": ["10.1089/ars.2007.1575", "17511584"]}, {"Citation": "Wang C., Zhou J., Wang J., Li S., Fukunaga A., Yodoi J., Tian H. Progress in the mechanism and targeted drug therapy for COPD. Signal Transduct. Target. Ther. 2020;5:248. doi: 10.1038/s41392-020-00345-x.", "ArticleIdList": ["10.1038/s41392-020-00345-x", "PMC7588592", "33110061"]}, {"Citation": "Rahman I., Biswas S.K., Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006;533:222\u2013239. doi: 10.1016/j.ejphar.2005.12.087.", "ArticleIdList": ["10.1016/j.ejphar.2005.12.087", "16500642"]}, {"Citation": "Winterbourn C.C., Kettle A.J. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic. Biol. Med. 2000;29:403\u2013409. doi: 10.1016/S0891-5849(00)00204-5.", "ArticleIdList": ["10.1016/S0891-5849(00)00204-5", "11020661"]}, {"Citation": "Barnes P.J. Novel signal transduction modulators for the treatment of airway diseases. Pharmacol. Ther. 2006;109:238\u2013245. doi: 10.1016/j.pharmthera.2005.08.001.", "ArticleIdList": ["10.1016/j.pharmthera.2005.08.001", "16171872"]}, {"Citation": "Gilmore T.D. Introduction to NF-kappaB: Players, pathways, perspectives. Oncogene. 2006;25:6680\u20136684. doi: 10.1038/sj.onc.1209954.", "ArticleIdList": ["10.1038/sj.onc.1209954", "17072321"]}, {"Citation": "Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007;8:49\u201362. doi: 10.1038/nrm2083.", "ArticleIdList": ["10.1038/nrm2083", "17183360"]}, {"Citation": "Leikauf G.D., Simpson L.G., Santrock J., Zhao Q., Abbinante-Nissen J., Zhou S., Driscoll K.E. Airway epithelial cell responses to ozone injury. Environ. Health Perspect. 1995;103((Suppl. 2)):91\u201395. doi: 10.1289/ehp.95103s291.", "ArticleIdList": ["10.1289/ehp.95103s291", "PMC1518831", "7614953"]}, {"Citation": "Marumo S., Hoshino Y., Kiyokawa H., Tanabe N., Sato A., Ogawa E., Muro S., Hirai T., Mishima M. p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice. BMC Pulm. Med. 2014;14:79. doi: 10.1186/1471-2466-14-79.", "ArticleIdList": ["10.1186/1471-2466-14-79", "PMC4024315", "24885161"]}, {"Citation": "Holmgren A., Buchanan B.B., Wolosiuk R.A. Photosynthetic regulatory protein from rabbit liver is identical with thioredoxin. FEBS Lett. 1977;82:351\u2013354. doi: 10.1016/0014-5793(77)80619-4.", "ArticleIdList": ["10.1016/0014-5793(77)80619-4", "334570"]}, {"Citation": "Yatmaz S., Seow H.J., Gualano R.C., Wong Z.X., Stambas J., Selemidis S., Crack P.J., Bozinovski S., Anderson G.P., Vlahos R. Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation. Am. J. Respir. Cell Mol. Biol. 2013;48:17\u201326. doi: 10.1165/rcmb.2011-0345OC.", "ArticleIdList": ["10.1165/rcmb.2011-0345OC", "23002098"]}, {"Citation": "Chae H.Z., Robison K., Poole L.B., Church G., Storz G., Rhee S.G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: Alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA. 1994;91:7017\u20137021. doi: 10.1073/pnas.91.15.7017.", "ArticleIdList": ["10.1073/pnas.91.15.7017", "PMC44329", "8041738"]}, {"Citation": "Lehtonen S.T., Markkanen P.M., Peltoniemi M., Kang S.W., Kinnula V.L. Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. Am. J. Physiol. Lung Cell Mol. Physiol. 2005;288:L997\u2013L1001. doi: 10.1152/ajplung.00432.2004.", "ArticleIdList": ["10.1152/ajplung.00432.2004", "15626747"]}, {"Citation": "Das K.C., Das C.K. Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: Redox independent functions. Biochem. Biophys. Res. Commun. 2000;277:443\u2013447. doi: 10.1006/bbrc.2000.3689.", "ArticleIdList": ["10.1006/bbrc.2000.3689", "11032742"]}, {"Citation": "Tamura T., Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA. 1996;93:1006\u20131011. doi: 10.1073/pnas.93.3.1006.", "ArticleIdList": ["10.1073/pnas.93.3.1006", "PMC40020", "8577704"]}, {"Citation": "Shaheen S.O. Antioxidants and respiratory disease: The uric acid paradox. Thorax. 2014;69:978\u2013979. doi: 10.1136/thoraxjnl-2014-205751.", "ArticleIdList": ["10.1136/thoraxjnl-2014-205751", "25122087"]}, {"Citation": "Hemila H., Louhiala P. Vitamin C may affect lung infections. J. R. Soc. Med. 2007;100:495\u2013498. doi: 10.1177/014107680710001109.", "ArticleIdList": ["10.1177/014107680710001109", "PMC2099400", "18048704"]}, {"Citation": "Miyazawa T., Burdeos G.C., Itaya M., Nakagawa K., Miyazawa T. Vitamin E: Regulatory Redox Interactions. IUBMB Life. 2019;71:430\u2013441. doi: 10.1002/iub.2008.", "ArticleIdList": ["10.1002/iub.2008", "30681767"]}, {"Citation": "Abed D.A., Goldstein M., Albanyan H., Jin H., Hu L. Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. Acta Pharm. Sin. B. 2015;5:285\u2013299. doi: 10.1016/j.apsb.2015.05.008.", "ArticleIdList": ["10.1016/j.apsb.2015.05.008", "PMC4629420", "26579458"]}, {"Citation": "Sun X., Chen L., He Z. PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease. Curr. Drug Metab. 2019;20:301\u2013304. doi: 10.2174/1389200220666190227224748.", "ArticleIdList": ["10.2174/1389200220666190227224748", "30827233"]}, {"Citation": "Olmos Y., Valle I., Borniquel S., Tierrez A., Soria E., Lamas S., Monsalve M. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J. Biol. Chem. 2009;284:14476\u201314484. doi: 10.1074/jbc.M807397200.", "ArticleIdList": ["10.1074/jbc.M807397200", "PMC2682896", "19324885"]}, {"Citation": "Meiners S., Eickelberg O., Konigshoff M. Hallmarks of the ageing lung. Eur. Respir. J. 2015;45:807\u2013827. doi: 10.1183/09031936.00186914.", "ArticleIdList": ["10.1183/09031936.00186914", "25657021"]}, {"Citation": "Birch J., Anderson R.K., Correia-Melo C., Jurk D., Hewitt G., Marques F.M., Green N.J., Moisey E., Birrell M.A., Belvisi M.G., et al. DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2015;309:L1124\u2013L1137. doi: 10.1152/ajplung.00293.2015.", "ArticleIdList": ["10.1152/ajplung.00293.2015", "PMC4652155", "26386121"]}, {"Citation": "Brandenberger C., Muhlfeld C. Mechanisms of lung aging. Cell Tissue Res. 2017;367:469\u2013480. doi: 10.1007/s00441-016-2511-x.", "ArticleIdList": ["10.1007/s00441-016-2511-x", "27743206"]}, {"Citation": "Quirk J.D., Sukstanskii A.L., Woods J.C., Lutey B.A., Conradi M.S., Gierada D.S., Yusen R.D., Castro M., Yablonskiy D.A. Experimental evidence of age-related adaptive changes in human acinar airways. J. Appl. Physiol. 2016;120:159\u2013165. doi: 10.1152/japplphysiol.00541.2015.", "ArticleIdList": ["10.1152/japplphysiol.00541.2015", "PMC4719056", "26542518"]}, {"Citation": "Kurozumi M., Matsushita T., Hosokawa M., Takeda T. Age-related changes in lung structure and function in the senescence-accelerated mouse (SAM): SAM-P/1 as a new murine model of senile hyperinflation of lung. Am. J. Respir. Crit. Care Med. 1994;149:776\u2013782. doi: 10.1164/ajrccm.149.3.8118649.", "ArticleIdList": ["10.1164/ajrccm.149.3.8118649", "8118649"]}, {"Citation": "Sato A., Hirai T., Imura A., Kita N., Iwano A., Muro S., Nabeshima Y., Suki B., Mishima M. Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc. Natl. Acad. Sci. USA. 2007;104:2361\u20132365. doi: 10.1073/pnas.0607882104.", "ArticleIdList": ["10.1073/pnas.0607882104", "PMC1892918", "17284608"]}, {"Citation": "Ravikumar P., Ye J., Zhang J., Pinch S.N., Hu M.C., Kuro-o M., Hsia C.C., Moe O.W. alpha-Klotho protects against oxidative damage in pulmonary epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2014;307:L566\u2013L575. doi: 10.1152/ajplung.00306.2013.", "ArticleIdList": ["10.1152/ajplung.00306.2013", "PMC4187038", "25063799"]}, {"Citation": "Gao W., Yuan C., Zhang J., Li L., Yu L., Wiegman C.H., Barnes P.J., Adcock I.M., Huang M., Yao X. Klotho expression is reduced in COPD airway epithelial cells: Effects on inflammation and oxidant injury. Clin. Sci. 2015;129:1011\u20131023. doi: 10.1042/CS20150273.", "ArticleIdList": ["10.1042/CS20150273", "PMC4613497", "26201096"]}, {"Citation": "Pako J., Barta I., Balogh Z., Kerti M., Drozdovszky O., Bikov A., Antus B., Horvath I., Varga J. Assessment of the Anti-Aging Klotho Protein in Patients with COPD Undergoing Pulmonary Rehabilitation. COPD J. Chronic Obstr. Pulm. Dis. 2017;14:176\u2013180. doi: 10.1080/15412555.2016.1272563.", "ArticleIdList": ["10.1080/15412555.2016.1272563", "28112974"]}, {"Citation": "Lange P., Celli B., Agusti A., Boje Jensen G., Divo M., Faner R., Guerra S., Marott J.L., Martinez F.D., Martinez-Camblor P., et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 2015;373:111\u2013122. doi: 10.1056/NEJMoa1411532.", "ArticleIdList": ["10.1056/NEJMoa1411532", "26154786"]}, {"Citation": "Lopez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell. 2013;153:1194\u20131217. doi: 10.1016/j.cell.2013.05.039.", "ArticleIdList": ["10.1016/j.cell.2013.05.039", "PMC3836174", "23746838"]}, {"Citation": "Reichert S., Stier A. Does oxidative stress shorten telomeres in vivo? A review. Biol. Lett. 2017;13 doi: 10.1098/rsbl.2017.0463.", "ArticleIdList": ["10.1098/rsbl.2017.0463", "PMC5746531", "29212750"]}, {"Citation": "Shammas M.A. Telomeres, lifestyle, cancer, and aging. Curr. Opin. Clin. Nutr. Metab. Care. 2011;14:28\u201334. doi: 10.1097/MCO.0b013e32834121b1.", "ArticleIdList": ["10.1097/MCO.0b013e32834121b1", "PMC3370421", "21102320"]}, {"Citation": "Stanley S.E., Chen J.J., Podlevsky J.D., Alder J.K., Hansel N.N., Mathias R.A., Qi X., Rafaels N.M., Wise R.A., Silverman E.K., et al. Telomerase mutations in smokers with severe emphysema. J. Clin. Investig. 2015;125:563\u2013570. doi: 10.1172/JCI78554.", "ArticleIdList": ["10.1172/JCI78554", "PMC4319417", "25562321"]}, {"Citation": "Cordoba-Lanus E., Cazorla-Rivero S., Espinoza-Jimenez A., de-Torres J.P., Pajares M.J., Aguirre-Jaime A., Celli B., Casanova C. Telomere shortening and accelerated aging in COPD: Findings from the BODE cohort. Respir. Res. 2017;18:59. doi: 10.1186/s12931-017-0547-4.", "ArticleIdList": ["10.1186/s12931-017-0547-4", "PMC5390353", "28407775"]}, {"Citation": "Alder J.K., Barkauskas C.E., Limjunyawong N., Stanley S.E., Kembou F., Tuder R.M., Hogan B.L., Mitzner W., Armanios M. Telomere dysfunction causes alveolar stem cell failure. Proc. Natl. Acad. Sci. USA. 2015;112:5099\u20135104. doi: 10.1073/pnas.1504780112.", "ArticleIdList": ["10.1073/pnas.1504780112", "PMC4413294", "25840590"]}, {"Citation": "Meyer K.C., Rosenthal N.S., Soergel P., Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech. Ageing Dev. 1998;104:169\u2013181. doi: 10.1016/S0047-6374(98)00065-7.", "ArticleIdList": ["10.1016/S0047-6374(98)00065-7", "9792195"]}, {"Citation": "Moliva J.I., Rajaram M.V., Sidiki S., Sasindran S.J., Guirado E., Pan X.J., Wang S.H., Ross P., Jr., Lafuse W.P., Schlesinger L.S., et al. Molecular composition of the alveolar lining fluid in the aging lung. Age. 2014;36:9633. doi: 10.1007/s11357-014-9633-4.", "ArticleIdList": ["10.1007/s11357-014-9633-4", "PMC4082594", "24584696"]}, {"Citation": "Ferrucci L., Harris T.B., Guralnik J.M., Tracy R.P., Corti M.C., Cohen H.J., Penninx B., Pahor M., Wallace R., Havlik R.J. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 1999;47:639\u2013646. doi: 10.1111/j.1532-5415.1999.tb01583.x.", "ArticleIdList": ["10.1111/j.1532-5415.1999.tb01583.x", "10366160"]}, {"Citation": "Giovannini S., Onder G., Liperoti R., Russo A., Carter C., Capoluongo E., Pahor M., Bernabei R., Landi F. Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J. Am. Geriatr. Soc. 2011;59:1679\u20131685. doi: 10.1111/j.1532-5415.2011.03570.x.", "ArticleIdList": ["10.1111/j.1532-5415.2011.03570.x", "PMC4321727", "21883115"]}, {"Citation": "Michaud M., Balardy L., Moulis G., Gaudin C., Peyrot C., Vellas B., Cesari M., Nourhashemi F. Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc. 2013;14:877\u2013882. doi: 10.1016/j.jamda.2013.05.009.", "ArticleIdList": ["10.1016/j.jamda.2013.05.009", "23792036"]}, {"Citation": "Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244\u2013254. doi: 10.1111/j.1749-6632.2000.tb06651.x.", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb06651.x", "10911963"]}, {"Citation": "Watanabe S., Kawamoto S., Ohtani N., Hara E. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases. Cancer Sci. 2017;108:563\u2013569. doi: 10.1111/cas.13184.", "ArticleIdList": ["10.1111/cas.13184", "PMC5406532", "28165648"]}, {"Citation": "Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol. 2010;5:99\u2013118. doi: 10.1146/annurev-pathol-121808-102144.", "ArticleIdList": ["10.1146/annurev-pathol-121808-102144", "PMC4166495", "20078217"]}, {"Citation": "Freund A., Patil C.K., Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011;30:1536\u20131548. doi: 10.1038/emboj.2011.69.", "ArticleIdList": ["10.1038/emboj.2011.69", "PMC3102277", "21399611"]}, {"Citation": "Baraldo S., Bazzan E., Zanin M.E., Turato G., Garbisa S., Maestrelli P., Papi A., Miniati M., Fabbri L.M., Zuin R., et al. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest. 2007;132:1733\u20131740. doi: 10.1378/chest.06-2819.", "ArticleIdList": ["10.1378/chest.06-2819", "17646237"]}, {"Citation": "Ranes J., Stoller J.K. A review of alpha-1 antitrypsin deficiency. Semin. Respir. Crit. Care Med. 2005;26:154\u2013166. doi: 10.1055/s-2005-869536.", "ArticleIdList": ["10.1055/s-2005-869536", "16088434"]}, {"Citation": "Marwick J.A., Chung K.F. Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2010;5:297\u2013309. doi: 10.2147/COPD.S7390.", "ArticleIdList": ["10.2147/COPD.S7390", "PMC2939685", "20856829"]}, {"Citation": "Barnes P.J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2013;131:636\u2013645. doi: 10.1016/j.jaci.2012.12.1564.", "ArticleIdList": ["10.1016/j.jaci.2012.12.1564", "23360759"]}, {"Citation": "Barnes P.J. Glucocorticosteroids: Current and future directions. Br. J. Pharmacol. 2011;163:29\u201343. doi: 10.1111/j.1476-5381.2010.01199.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.01199.x", "PMC3085866", "21198556"]}, {"Citation": "Vernooy J.H., Lindeman J.H., Jacobs J.A., Hanemaaijer R., Wouters E.F. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest. 2004;126:1802\u20131810. doi: 10.1378/chest.126.6.1802.", "ArticleIdList": ["10.1378/chest.126.6.1802", "15596677"]}, {"Citation": "Omachi T.A., Eisner M.D., Rames A., Markovtsova L., Blanc P.D. Matrix metalloproteinase-9 predicts pulmonary status declines in alpha1-antitrypsin deficiency. Respir. Res. 2011;12:35. doi: 10.1186/1465-9921-12-35.", "ArticleIdList": ["10.1186/1465-9921-12-35", "PMC3073899", "21429222"]}, {"Citation": "Harman D. The Free Radical Theory of Aging: Effect of Age on Serum Copper Levels. J. Gerontol. 1965;20:151\u2013153. doi: 10.1093/geronj/20.2.151.", "ArticleIdList": ["10.1093/geronj/20.2.151", "14284786"]}, {"Citation": "Harman D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956;11:298\u2013300. doi: 10.1093/geronj/11.3.298.", "ArticleIdList": ["10.1093/geronj/11.3.298", "13332224"]}, {"Citation": "Gladyshev V.N. The free radical theory of aging is dead. Long live the damage theory! Antioxid. Redox Signal. 2014;20:727\u2013731. doi: 10.1089/ars.2013.5228.", "ArticleIdList": ["10.1089/ars.2013.5228", "PMC3901353", "24159899"]}, {"Citation": "Doonan R., McElwee J.J., Matthijssens F., Walker G.A., Houthoofd K., Back P., Matscheski A., Vanfleteren J.R., Gems D. Against the oxidative damage theory of aging: Superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008;22:3236\u20133241. doi: 10.1101/gad.504808.", "ArticleIdList": ["10.1101/gad.504808", "PMC2600764", "19056880"]}, {"Citation": "Mesquita A., Weinberger M., Silva A., Sampaio-Marques B., Almeida B., Leao C., Costa V., Rodrigues F., Burhans W.C., Ludovico P. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity. Proc. Natl. Acad. Sci. USA. 2010;107:15123\u201315128. doi: 10.1073/pnas.1004432107.", "ArticleIdList": ["10.1073/pnas.1004432107", "PMC2930563", "20696905"]}, {"Citation": "Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.T., et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genom. 2003;16:29\u201337. doi: 10.1152/physiolgenomics.00122.2003.", "ArticleIdList": ["10.1152/physiolgenomics.00122.2003", "14679299"]}, {"Citation": "Ansari A., Rahman M.S., Saha S.K., Saikot F.K., Deep A., Kim K.H. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell. 2017;16:4\u201316. doi: 10.1111/acel.12538.", "ArticleIdList": ["10.1111/acel.12538", "PMC5242307", "27686535"]}, {"Citation": "Sosulski M.L., Gongora R., Feghali-Bostwick C., Lasky J.A., Sanchez C.G. Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis. J. Gerontol. A Biol. Sci. Med. Sci. 2017;72:595\u2013602. doi: 10.1093/gerona/glw151.", "ArticleIdList": ["10.1093/gerona/glw151", "PMC5964739", "27522058"]}, {"Citation": "Zhang M., Zhang Y., Roth M., Zhang L., Shi R., Yang X., Li Y., Zhang J. Sirtuin 3 Inhibits Airway Epithelial Mitochondrial Oxidative Stress in Cigarette Smoke-Induced COPD. Oxid. Med. Cell. Longev. 2020;2020:7582980. doi: 10.1155/2020/7582980.", "ArticleIdList": ["10.1155/2020/7582980", "PMC7503124", "33005288"]}, {"Citation": "Paul M.K., Bisht B., Darmawan D.O., Chiou R., Ha V.L., Wallace W.D., Chon A.T., Hegab A.E., Grogan T., Elashoff D.A., et al. Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling. Cell Stem Cell. 2014;15:199\u2013214. doi: 10.1016/j.stem.2014.05.009.", "ArticleIdList": ["10.1016/j.stem.2014.05.009", "PMC4127166", "24953182"]}, {"Citation": "Swamy S.M., Rajasekaran N.S., Thannickal V.J. Nuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung Fibrosis. Am. J. Pathol. 2016;186:1712\u20131723. doi: 10.1016/j.ajpath.2016.02.022.", "ArticleIdList": ["10.1016/j.ajpath.2016.02.022", "PMC4929397", "27338106"]}, {"Citation": "Suzuki M., Betsuyaku T., Ito Y., Nagai K., Nasuhara Y., Kaga K., Kondo S., Nishimura M. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2008;39:673\u2013682. doi: 10.1165/rcmb.2007-0424OC.", "ArticleIdList": ["10.1165/rcmb.2007-0424OC", "18566336"]}, {"Citation": "Hwang J.W., Rajendrasozhan S., Yao H., Chung S., Sundar I.K., Huyck H.L., Pryhuber G.S., Kinnula V.L., Rahman I. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. J. Immunol. 2011;187:987\u2013998. doi: 10.4049/jimmunol.1001861.", "ArticleIdList": ["10.4049/jimmunol.1001861", "PMC3131437", "21690325"]}, {"Citation": "Barnes P.J., Baker J., Donnelly L.E. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am. J. Respir. Crit. Care Med. 2019;200:556\u2013564. doi: 10.1164/rccm.201810-1975TR.", "ArticleIdList": ["10.1164/rccm.201810-1975TR", "30860857"]}, {"Citation": "Paredi P., Kharitonov S.A., Barnes P.J. Analysis of expired air for oxidation products. Am. J. Respir. Crit. Care Med. 2002;166:S31\u2013S37. doi: 10.1164/rccm.2206012.", "ArticleIdList": ["10.1164/rccm.2206012", "12471086"]}, {"Citation": "Paredi P., Kharitonov S.A., Leak D., Ward S., Cramer D., Barnes P.J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000;162:369\u2013373. doi: 10.1164/ajrccm.162.2.9909025.", "ArticleIdList": ["10.1164/ajrccm.162.2.9909025", "10934055"]}, {"Citation": "Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996;154:813\u2013816. doi: 10.1164/ajrccm.154.3.8810624.", "ArticleIdList": ["10.1164/ajrccm.154.3.8810624", "8810624"]}, {"Citation": "Corradi M., Pignatti P., Manini P., Andreoli R., Goldoni M., Poppa M., Moscato G., Balbi B., Mutti A. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur. Respir. J. 2004;24:1011\u20131017. doi: 10.1183/09031936.04.00002404.", "ArticleIdList": ["10.1183/09031936.04.00002404", "PMC1430385", "15572547"]}, {"Citation": "Marwick J.A., Kirkham P.A., Stevenson C.S., Danahay H., Giddings J., Butler K., Donaldson K., Macnee W., Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am. J. Respir. Cell Mol. Biol. 2004;31:633\u2013642. doi: 10.1165/rcmb.2004-0006OC.", "ArticleIdList": ["10.1165/rcmb.2004-0006OC", "15333327"]}, {"Citation": "Kinnula V.L., Ilumets H., Myllarniemi M., Sovijarvi A., Rytila P. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur. Respir. J. 2007;29:51\u201355. doi: 10.1183/09031936.00023606.", "ArticleIdList": ["10.1183/09031936.00023606", "17050565"]}, {"Citation": "Biernacki W.A., Kharitonov S.A., Barnes P.J. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax. 2003;58:294\u2013298. doi: 10.1136/thorax.58.4.294.", "ArticleIdList": ["10.1136/thorax.58.4.294", "PMC1746632", "12668789"]}, {"Citation": "Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998;157:1418\u20131422. doi: 10.1164/ajrccm.157.5.9709032.", "ArticleIdList": ["10.1164/ajrccm.157.5.9709032", "9603117"]}, {"Citation": "Schmidt S.A., Johansen M.B., Olsen M., Xu X., Parker J.M., Molfino N.A., Lash T.L., Sorensen H.T., Christiansen C.F. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: A registry-based cohort study. BMJ Open. 2014;4:e006720. doi: 10.1136/bmjopen-2014-006720.", "ArticleIdList": ["10.1136/bmjopen-2014-006720", "PMC4275660", "25526796"]}, {"Citation": "Drost E.M., Skwarski K.M., Sauleda J., Soler N., Roca J., Agusti A., MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005;60:293\u2013300. doi: 10.1136/thx.2004.027946.", "ArticleIdList": ["10.1136/thx.2004.027946", "PMC1747355", "15790984"]}, {"Citation": "Tanabe N., Muro S., Hirai T., Oguma T., Terada K., Marumo S., Kinose D., Ogawa E., Hoshino Y., Mishima M. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2011;183:1653\u20131659. doi: 10.1164/rccm.201009-1535OC.", "ArticleIdList": ["10.1164/rccm.201009-1535OC", "21471102"]}, {"Citation": "Woodhead M., Blasi F., Ewig S., Huchon G., Ieven M., Ortqvist A., Schaberg T., Torres A., van der Heijden G., Verheij T.J., et al. Guidelines for the management of adult lower respiratory tract infections. Eur. Respir. J. 2005;26:1138\u20131180. doi: 10.1183/09031936.05.00055705.", "ArticleIdList": ["10.1183/09031936.05.00055705", "16319346"]}, {"Citation": "Tanabe N., Hoshino Y., Marumo S., Kiyokawa H., Sato S., Kinose D., Uno K., Muro S., Hirai T., Yodoi J., et al. Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation. PLoS ONE. 2013;8:e79016. doi: 10.1371/journal.pone.0079016.", "ArticleIdList": ["10.1371/journal.pone.0079016", "PMC3823967", "24244404"]}, {"Citation": "Lomas D.A. Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease? Ann. Am. Thorac. Soc. 2016;13((Suppl. 2)):S130\u2013S137. doi: 10.1513/AnnalsATS.201504-196KV.", "ArticleIdList": ["10.1513/AnnalsATS.201504-196KV", "27115947"]}, {"Citation": "Fischer B.M., Pavlisko E., Voynow J.A. Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation. Int. J. Chron. Obstruct. Pulmon. Dis. 2011;6:413\u2013421. doi: 10.2147/COPD.S10770.", "ArticleIdList": ["10.2147/COPD.S10770", "PMC3157944", "21857781"]}, {"Citation": "Rahman I., Morrison D., Donaldson K., MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 1996;154:1055\u20131060. doi: 10.1164/ajrccm.154.4.8887607.", "ArticleIdList": ["10.1164/ajrccm.154.4.8887607", "8887607"]}, {"Citation": "Liu J., Huang J., Liu H., Chen C., Xu J., Zhong L. Elevated serum 4HNE plus decreased serum thioredoxin: Unique feature and implications for acute exacerbation of chronic obstructive pulmonary disease. PLoS ONE. 2021;16:e0245810. doi: 10.1371/journal.pone.0245810.", "ArticleIdList": ["10.1371/journal.pone.0245810", "PMC7833214", "33493155"]}, {"Citation": "Bernardo I., Bozinovski S., Vlahos R. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities. Pharmacol. Ther. 2015;155:60\u201379. doi: 10.1016/j.pharmthera.2015.08.005.", "ArticleIdList": ["10.1016/j.pharmthera.2015.08.005", "26297673"]}, {"Citation": "Barreiro E., Peinado V.I., Galdiz J.B., Ferrer E., Marin-Corral J., Sanchez F., Gea J., Barbera J.A. Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am. J. Respir. Crit. Care Med. 2010;182:477\u2013488. doi: 10.1164/rccm.200908-1220OC.", "ArticleIdList": ["10.1164/rccm.200908-1220OC", "20413628"]}, {"Citation": "Kiyokawa H., Muro S., Oguma T., Sato S., Tanabe N., Takahashi T., Kudo M., Kinose D., Kondoh H., Kubo T., et al. Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD J. Chronic Obstr. Pulm. Dis. 2012;9:235\u2013242. doi: 10.3109/15412555.2011.650243.", "ArticleIdList": ["10.3109/15412555.2011.650243", "PMC3399638", "22360380"]}, {"Citation": "Tanimura K., Sato S., Sato A., Tanabe N., Hasegawa K., Uemasu K., Hamakawa Y., Oguma T., Muro S., Hirai T. Accelerated Loss of Antigravity Muscles Is Associated with Mortality in Patients with COPD. Respiration. 2020;99:298\u2013306. doi: 10.1159/000506520.", "ArticleIdList": ["10.1159/000506520", "32235124"]}, {"Citation": "To Y., Ito K., Kizawa Y., Failla M., Ito M., Kusama T., Elliott W.M., Hogg J.C., Adcock I.M., Barnes P.J. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010;182:897\u2013904. doi: 10.1164/rccm.200906-0937OC.", "ArticleIdList": ["10.1164/rccm.200906-0937OC", "PMC2970861", "20224070"]}, {"Citation": "Hashimoto S., Matsumoto K., Gon Y., Furuichi S., Maruoka S., Takeshita I., Hirota K., Yodoi J., Horie T. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 1999;258:443\u2013447. doi: 10.1006/bbrc.1999.0658.", "ArticleIdList": ["10.1006/bbrc.1999.0658", "10329406"]}, {"Citation": "Sato A., Hoshino Y., Hara T., Muro S., Nakamura H., Mishima M., Yodoi J. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. J. Pharmacol. Exp. Ther. 2008;325:380\u2013388. doi: 10.1124/jpet.107.134007.", "ArticleIdList": ["10.1124/jpet.107.134007", "18256171"]}, {"Citation": "Laurent T.C., Moore E.C., Reichard P. Enzymatic Synthesis of Deoxyribonucleotides. Iv. Isolation and Characterization of Thioredoxin, the Hydrogen Donor from Escherichia Coli B. J. Biol. Chem. 1964;239:3436\u20133444. doi: 10.1016/S0021-9258(18)97742-2.", "ArticleIdList": ["10.1016/S0021-9258(18)97742-2", "14245400"]}, {"Citation": "Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 1994;42:75\u201380. doi: 10.1016/0165-2478(94)90038-8.", "ArticleIdList": ["10.1016/0165-2478(94)90038-8", "7829134"]}, {"Citation": "Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 1997;15:351\u2013369. doi: 10.1146/annurev.immunol.15.1.351.", "ArticleIdList": ["10.1146/annurev.immunol.15.1.351", "9143692"]}, {"Citation": "Nakamura H., Herzenberg L.A., Bai J., Araya S., Kondo N., Nishinaka Y., Herzenberg L.A., Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc. Natl. Acad. Sci. USA. 2001;98:15143\u201315148. doi: 10.1073/pnas.191498798.", "ArticleIdList": ["10.1073/pnas.191498798", "PMC64997", "11742067"]}, {"Citation": "Sato N., Iwata S., Nakamura K., Hori T., Mori K., Yodoi J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol. 1995;154:3194\u20133203.", "ArticleIdList": ["7897207"]}, {"Citation": "Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17:2596\u20132606. doi: 10.1093/emboj/17.9.2596.", "ArticleIdList": ["10.1093/emboj/17.9.2596", "PMC1170601", "9564042"]}, {"Citation": "Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 1997;94:3633\u20133638. doi: 10.1073/pnas.94.8.3633.", "ArticleIdList": ["10.1073/pnas.94.8.3633", "PMC20492", "9108029"]}, {"Citation": "Okamoto T., Ogiwara H., Hayashi T., Mitsui A., Kawabe T., Yodoi J. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 1992;4:811\u2013819. doi: 10.1093/intimm/4.7.811.", "ArticleIdList": ["10.1093/intimm/4.7.811", "1498089"]}, {"Citation": "Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 1999;274:35809\u201335815. doi: 10.1074/jbc.274.50.35809.", "ArticleIdList": ["10.1074/jbc.274.50.35809", "10585464"]}, {"Citation": "Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999;274:21645\u201321650. doi: 10.1074/jbc.274.31.21645.", "ArticleIdList": ["10.1074/jbc.274.31.21645", "10419473"]}, {"Citation": "Kondo N., Ishii Y., Kwon Y.W., Tanito M., Horita H., Nishinaka Y., Nakamura H., Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J. Immunol. 2004;172:442\u2013448. doi: 10.4049/jimmunol.172.1.442.", "ArticleIdList": ["10.4049/jimmunol.172.1.442", "14688353"]}, {"Citation": "Kasuno K., Nakamura H., Ono T., Muso E., Yodoi J. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int. 2003;64:1273\u20131282. doi: 10.1046/j.1523-1755.2003.00224.x.", "ArticleIdList": ["10.1046/j.1523-1755.2003.00224.x", "12969145"]}, {"Citation": "Nakamura H., Tamura S., Watanabe I., Iwasaki T., Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol. Lett. 2002;82:165\u2013170. doi: 10.1016/S0165-2478(02)00033-0.", "ArticleIdList": ["10.1016/S0165-2478(02)00033-0", "12008049"]}, {"Citation": "Okuyama H., Nakamura H., Shimahara Y., Uyama N., Kwon Y.W., Kawada N., Yamaoka Y., Yodoi J. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J. Hepatol. 2005;42:117\u2013123. doi: 10.1016/j.jhep.2004.09.020.", "ArticleIdList": ["10.1016/j.jhep.2004.09.020", "15629516"]}, {"Citation": "Ueda S., Nakamura T., Yamada A., Teratani A., Matsui N., Furukawa S., Hoshino Y., Narita M., Yodoi J., Nakamura H. Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat. Life Sci. 2006;79:1170\u20131177. doi: 10.1016/j.lfs.2006.03.026.", "ArticleIdList": ["10.1016/j.lfs.2006.03.026", "16643955"]}, {"Citation": "Hattori I., Takagi Y., Nakamura H., Nozaki K., Bai J., Kondo N., Sugino T., Nishimura M., Hashimoto N., Yodoi J. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid. Redox Signal. 2004;6:81\u201387. doi: 10.1089/152308604771978372.", "ArticleIdList": ["10.1089/152308604771978372", "14713338"]}, {"Citation": "Ohashi S., Nishio A., Nakamura H., Kido M., Ueno S., Uza N., Inoue S., Kitamura H., Kiriya K., Asada M., et al. Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006;290:G772\u2013G781. doi: 10.1152/ajpgi.00425.2005.", "ArticleIdList": ["10.1152/ajpgi.00425.2005", "16322089"]}, {"Citation": "Farina A.R., Tacconelli A., Cappabianca L., Masciulli M.P., Holmgren A., Beckett G.J., Gulino A., Mackay A.R. Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion. Eur. J. Biochem. 2001;268:405\u2013413. doi: 10.1046/j.1432-1033.2001.01892.x.", "ArticleIdList": ["10.1046/j.1432-1033.2001.01892.x", "11168376"]}, {"Citation": "Meftahi G.H., Jangravi Z., Sahraei H., Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: The contribution of \u201cinflame-aging\u201d. Inflamm. Res. 2020;69:825\u2013839. doi: 10.1007/s00011-020-01372-8.", "ArticleIdList": ["10.1007/s00011-020-01372-8", "PMC7289226", "32529477"]}, {"Citation": "Miwa K., Kishimoto C., Nakamura H., Makita T., Ishii K., Okuda N., Yodoi J., Sasayama S. Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors. Circ. J. 2005;69:291\u2013294. doi: 10.1253/circj.69.291.", "ArticleIdList": ["10.1253/circj.69.291", "15731533"]}, {"Citation": "Lehtonen S.T., Ohlmeier S., Kaarteenaho-Wiik R., Harju T., Paakko P., Soini Y., Kinnula V.L. Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation? Antioxid. Redox Signal. 2008;10:813\u2013819. doi: 10.1089/ars.2007.1952.", "ArticleIdList": ["10.1089/ars.2007.1952", "18179358"]}, {"Citation": "Hurst J.R., Vestbo J., Anzueto A., Locantore N., Mullerova H., Tal-Singer R., Miller B., Lomas D.A., Agusti A., Macnee W., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010;363:1128\u20131138. doi: 10.1056/NEJMoa0909883.", "ArticleIdList": ["10.1056/NEJMoa0909883", "20843247"]}, {"Citation": "Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 1989;6:593\u2013597. doi: 10.1016/0891-5849(89)90066-X.", "ArticleIdList": ["10.1016/0891-5849(89)90066-X", "2546864"]}, {"Citation": "Balansky R.B., D\u2019Agostini F., Zanacchi P., De Flora S. Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett. 1992;64:123\u2013131. doi: 10.1016/0304-3835(92)90072-4.", "ArticleIdList": ["10.1016/0304-3835(92)90072-4", "1611595"]}, {"Citation": "Huber G.L., Davies P., Zwilling G.R., Pochay V.E., Hinds W.C., Nicholas H.A., Mahajan V.K., Hayashi M., First M.W. A morphologic and physiologic bioassay for quantifying alterations in the lung following experimental chronic inhalation of tobacco smoke. Bull. Eur. Physiopathol. Respir. 1981;17:269\u2013327.", "ArticleIdList": ["6793114"]}, {"Citation": "Jeffery P.K., Rogers D.F., Ayers M.M. Effect of oral acetylcysteine on tobacco smoke-induced secretory cell hyperplasia. Eur. J. Respir. Dis. Suppl. 1985;139:117\u2013122.", "ArticleIdList": ["3862604"]}, {"Citation": "Rogers D.F., Godfrey R.W., Majumdar S., Jeffery P.K. Oral N-acetylcysteine speeds reversal of cigarette smoke-induced mucous cell hyperplasia in the rat. Exp. Lung Res. 1988;14:19\u201335. doi: 10.3109/01902148809062848.", "ArticleIdList": ["10.3109/01902148809062848", "3342780"]}, {"Citation": "Messier E.M., Day B.J., Bahmed K., Kleeberger S.R., Tuder R.M., Bowler R.P., Chu H.W., Mason R.J., Kosmider B. N-acetylcysteine protects murine alveolar type II cells from cigarette smoke injury in a nuclear erythroid 2-related factor-2-independent manner. Am. J. Respir. Cell Mol. Biol. 2013;48:559\u2013567. doi: 10.1165/rcmb.2012-0295OC.", "ArticleIdList": ["10.1165/rcmb.2012-0295OC", "PMC3707381", "23492188"]}, {"Citation": "Breau M., Houssaini A., Lipskaia L., Abid S., Born E., Marcos E., Czibik G., Attwe A., Beaulieu D., Palazzo A., et al. The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice. JCI Insight. 2019;4 doi: 10.1172/jci.insight.127647.", "ArticleIdList": ["10.1172/jci.insight.127647", "PMC6795405", "31578304"]}, {"Citation": "Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., van Schayck C.P., Olivieri D., Del Donno M., De Backer W., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial. Lancet. 2005;365:1552\u20131560. doi: 10.1016/S0140-6736(05)66456-2.", "ArticleIdList": ["10.1016/S0140-6736(05)66456-2", "15866309"]}, {"Citation": "Zheng J.P., Wen F.Q., Bai C.X., Wan H.Y., Kang J., Chen P., Yao W.Z., Ma L.J., Xia Q.K., Gao Y., et al. High-dose N-acetylcysteine in the prevention of COPD exacerbations: Rationale and design of the PANTHEON Study. COPD J. Chronic Obstr. Pulm. Dis. 2013;10:164\u2013171. doi: 10.3109/15412555.2012.732628.", "ArticleIdList": ["10.3109/15412555.2012.732628", "23061828"]}, {"Citation": "Papi A., Zheng J., Criner G.J., Fabbri L.M., Calverley P.M.A. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study. Respir. Med. 2019;147:37\u201343. doi: 10.1016/j.rmed.2018.12.014.", "ArticleIdList": ["10.1016/j.rmed.2018.12.014", "30704697"]}, {"Citation": "Cazzola M., Calzetta L., Page C., Jardim J., Chuchalin A.G., Rogliani P., Matera M.G. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: A meta-analysis. Eur. Respir. Rev. 2015;24:451\u2013461. doi: 10.1183/16000617.00002215.", "ArticleIdList": ["10.1183/16000617.00002215", "26324807"]}, {"Citation": "Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA. 2007;297:842\u2013857. doi: 10.1001/jama.297.8.842.", "ArticleIdList": ["10.1001/jama.297.8.842", "17327526"]}, {"Citation": "Sayin V.I., Ibrahim M.X., Larsson E., Nilsson J.A., Lindahl P., Bergo M.O. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 2014;6:221ra215. doi: 10.1126/scitranslmed.3007653.", "ArticleIdList": ["10.1126/scitranslmed.3007653", "24477002"]}, {"Citation": "Walters J.A., Tan D.J., White C.J., Gibson P.G., Wood-Baker R., Walters E.H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014:CD001288. doi: 10.1002/14651858.CD001288.pub4.", "ArticleIdList": ["10.1002/14651858.CD001288.pub4", "25178099"]}, {"Citation": "Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 2000;20:6891\u20136903. doi: 10.1128/MCB.20.18.6891-6903.2000.", "ArticleIdList": ["10.1128/MCB.20.18.6891-6903.2000", "PMC88765", "10958685"]}, {"Citation": "Renkema T.E., Schouten J.P., Koeter G.H., Postma D.S. Effects of long-term treatment with corticosteroids in COPD. Chest. 1996;109:1156\u20131162. doi: 10.1378/chest.109.5.1156.", "ArticleIdList": ["10.1378/chest.109.5.1156", "8625660"]}, {"Citation": "Sugiura H., Ichinose M., Yamagata S., Koarai A., Shirato K., Hattori T. Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD. Thorax. 2003;58:299\u2013305. doi: 10.1136/thorax.58.4.299.", "ArticleIdList": ["10.1136/thorax.58.4.299", "PMC1746645", "12668791"]}, {"Citation": "Profita M., Albano G.D., Montalbano A.M., Di Sano C., Anzalone G., Gagliardo R., Riccobono L., Bonanno A., Siena L., Pieper M.P., et al. Acetylcholine leads to signal transducer and activator of transcription 1 (STAT-1) mediated oxidative/nitrosative stress in human bronchial epithelial cell line. Biochim. Biophys. Acta. 2013;1832:1949\u20131958. doi: 10.1016/j.bbadis.2013.06.009.", "ArticleIdList": ["10.1016/j.bbadis.2013.06.009", "23811074"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "7"}, {"Year": "2021", "Month": "8", "Day": "27"}, {"Year": "2021", "Month": "9", "Day": "1"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "1", "Minute": "7"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["34573061", "PMC8470212", "10.3390/antiox10091429", "antiox10091429"]}}], "PubmedBookArticle": []}